Botanical Studies (2006) 47: 37-43.
*
Corresponding author: E-mail: wchou@tmu.edu.tw; Fax:
886(2) 2378-0134.
Structure-activity relationships of five myricetin
galloylglycosides from leaves of
Acacia confusa
Tzong-Huei LEE
1
, Der-Zen LIU
2
, Feng-Lin HSU
1
, Wen-Chung WU
1
, and Wen-Chi HoU
1*
1
Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei, Taiwan
2
Graduate Institute of Biomedical Materials, Taipei Medical University, Taipei, Taiwan
(Received June 30, 2005; Accepted September 7, 2005)
ABSTRACT.
Five structure-related myricetin galloylglycosides isolated from leaves of Acacia confusa
were previously reported (Lee et al., 2000, J. Nat. Prod., 63, 710-712). However, the structure-activity
relationships were not reported. In this research, the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging
activity, and inhibitory activities against semicarbazide-sensitive amine oxidase (SSAo) and angiotensin
converting enzyme (ACE) were compared among five compounds, namely, myricetin 3-O-(3"-O-galloyl)-α-
rhamnopyranoside 7-methyl ether (compound 1, 630 Da), myricetin 3-O-(2"-O-galloyl)-α-rhamnopyranoside
7-methyl ether (compound 2, 630 Da), myricetin 3-O-(2"-O-galloyl)-α-rhamnopyranoside (compound 3,
616 Da), myricetin 3-O-(3"-O-galloyl)-α-rhamnopyranoside (compound 4, 616 Da), myricetin 3-O-(2", 3"
-di-O-galloyl)-α-rhamnopyranoside (compound 5, 768 Da). For DPPH scavenging activity, the IC
50
for five
compounds was 591, 1522, 3210, 1389, and 867 μM, respectively. For SSAo inhibitory activity, the IC
50
for
five compounds was 36.16, 93.20, 119.50, 88.20, and 39.35 μM, respectively. The IC
5 0
of positive control
of semicarbazide was 34.21 μM. The five compounds have the same orders of compound 1> compound 5>
compound 4> compound 2> compound 3 for DPPH scavenging activity and SSAO inhibitiony. It was found
that gallic acid in the R
3
position was the key role for both biological activities. For ACE inhibitory activity,
compound 1, compound 2, and compound 5 showed dose-dependent inhibitory modes and the IC
50
was 60.32,
151.90, and 19.82 μM, respectively.
Keywords: Acacia confusa; Angiotensin converting enzyme (ACE); 1, 1-diphenyl-2-picrylhydrazyl (DPPH);
Myricetin galloylglycoside; Semicarbazide-sensitive amine oxidase (SSAo); Structure-activity relationships
(SAR).
INTRODUCTION
Free radical-mediated reactions are involved in
degenerative or pathological processes such as aging
(Harman, 1995), cancer, coronary heart disease, and
Alzheimer ’s disease (Ames, 1983; Smith et al., 1996; Diaz
et al., 1997). Meanwhile, there are many epidemiological
results revealing an association between a diet rich in
fresh fruit and vegetable and a decrease in the risk of
cardiovascular diseases and certain forms of cancer in
humans (Salah et al., 1995). Several reports concern
natural compounds in fruits and vegetables for their
antioxidant activities, such as phenolic compounds (Rice-
Evans et al., 1997), anthocyanin (Espin et al., 2000),
echinacoside in Echinaceae root (Hu and Kitts, 2000),
methanolic and hot-water extracts of Liriope spicata L.
(Hou et al., 2004), the storage proteins of sweet potato
root (Hou et al., 2001a), yam tuber (Hou et al., 2001b),
potato tuber (Liu et al., 2003b), and yam mucilages (Hou
et al., 2002; Lin et al., 2005).
The semicarbazide-sensitive amine oxidase (SSAo,
EC 1.4.3.6), which contains a cofactor of one or
more topaquinone, is a common name for a group of
heterogenous enzymes widely distributed in nature, in
plants, microorganisms, and the organs of mammals
(vasculature, dental pulp, eye and plasma) (Boomsma
et al., 2000). SSAo converts primary amines into the
corresponding aldehydes, generating hydrogen peroxide
and ammonia. It was found that the endogenous
compounds aminoacetone and methylamine are good
substrates for most SSAos (Precious et al., 1988). In
recent research, plasma SSAo was found raised in
diabetes mellitus and heart failure and implicated in
roles in atherosclerosis, endothelial damage, and glucose
transport into adipocytes (Yu and Zuo, 1993, 1996;
Boomsma et al., 1997, 2003).
Several classes of pharmacological agents have been
used in the treatment of hypertension (Mark and Davis,
2000). one class of anti-hypertensive drugs known as
angiotensin I converting enzyme (ACE) inhibitors (i.e.
peptidase inhibitors) has a low incidence of adverse side-
effects and is the preferred class of anti-hypertensive
agents when treating patients with concurrent secondary
BIOCHEMISTRY